Skip to main content

Table 1 Characteristics of patients with a Prior Approval for Restricted Antimicrobials (PARA) request between January 1 and December 31, 2016. Manila, Philippines. “Evaluating carbapenem restriction practices at a private hospital in Manila, Philippines as a strategy for antimicrobial stewardship”

From: Evaluating carbapenem restriction practices at a private hospital in Manila, Philippines as a strategy for antimicrobial stewardship

  Total
n (%)a
Definitive
n (%)
Empiric
n (%)
Prophylactic
n (%)
Group size (N) 185 56 127 2
Age (median years) 75.5 78.4 72.7 75.0
Gender (male) 83 (45%) 30 (54%) 52 (41%) 1 (50%)
Total # comorbidities of interest 268 83 183 2
Average # comorbidities per patient 1.45 1.48 1.44 1.00
 Chronic Obstructive Pulmonary Disorder 25 8 16 1
 Hypertension 102 36 66 0
 Diabetes Mellitus 66 23 43 0
 Malignancy (any, active) 51 9 41 1
 Hemodialysis 25 6 19 0
 None 28 7 20 1
Outcome
 Length of hospital days (median days) 14.0 14.5 14.0 15.0
 Mortality 42 (23%) 10 (18%) 32 (25%) 0 (0%)
 Cases with same recurrent infection within 30 days of discharge 14 (8%) 2 (4%) 12 (9%) 0 (0%)
 Duration of therapy (median days) 6.5 7.0 5.0 11.0
Site of infection for PARA request
 Respiratory 145 30 113 2
 Blood 18 8 10 0
 Gastrointestinal 1 1 0 0
 Genitourinary 39 24 15 0
 Wound/surgical site 2 1 1 0
  1. aPercentage within the column